Breast Cancer Protection Plan In Place, Roche Turns Attention To Hematology

With new drugs at hand to protect its Herceptin breast cancer franchise, Roche announced positive data for its rituximab replacement candidate and other steps in its plan to protect top-seller Rituxan/MabThera.